Reducing the Risk of Entering a New Therapeutic Category

A mid-market oncolytic manufacturer was about to expand into the vastly different therapeutic category of dermatology. After finding themselves with significant gaps in commercialization strategy development and operational execution in this new space, they knew they needed to seek out a partner to gain the insights and operational blueprints necessary for a successful category entry. Learn how this manufacturer was able to create a scalable commercialization strategy that was capable of accommodating current and future product archetypes and therapeutic categories. Download below!